Market Commentary For Monday July 10 2014 – Fear of Full Blown War In Middleast This equates to small caps and speculative biotech getting beaten up. As this situation in Israel intensifies, I expect selling to continue until the situation…
Author: Scott Matusow
Video + Market Commentary For Monday July 8 2014 – Earnings Alcoa Beats, Israel Situation
Market Commentary For Monday July 8 2014 – Earnings Alcoa Beats, Israel Situation $AA earnings beat nicely, so often times that one gives a good signal what to expect for this earnings season = most should meet or beat =…
Market Commentary For Monday After Market July 7 2014 – Bad Initial Timing On Halo
Market Commentary For Monday After Market July 7 2014 – Bad Initial Timing On Halo. I misread somewhat the mental effect of the buzz about the FED raising interest rates as the general market seems to believe that based on…
Catalyst Trade Alert: I Bought $HALO At $10.13
Catalyst Trade Alert: I Bought $HALO At $10.13. My target price is around $11.50, with a potential stop around $9.75 Catalyst-Binary Event-Advisory Committee July 31, 2014 HyQvia is a combination of human immune globulin (the drug being enhanced) and recombinant…
Video Market Commentary For Monday July 7 2014 – Earnings In Focus, Expect A Choppy Market
Market Commentary For Monday July 7 2014 – Earnings In Focus, Expect A Choppy Market. In this video, I give my forecast on what to expect this week in the market, which is choppiness. Many news outlets would have you…
Video Chart Reviews And Market Commentary For July 2, 2014- FPRX ACRX + More
Video Chart Reviews And Market Commentary For July 2, 2014- FPRX ACRX + More. A few people have been asking me to look at the FPRX chart, so in this video, I start out with that one. Additionally, I review…
Video: $ACRX Chart Review And Market Commentary For July 1, 2014
$ACRX Chart Reviww And Market Commentary For July 1, 2014 We think this one has a good shot at hitting the mid $12 range very soon. Additionally, as normally, I got the market moves from Thursday exactly right, which I…
AcelRx Should Trend Higher As FDA Approval Is Likely At End Of This Month
Summary AcelRx develops Zalviso to treat acute and breakthrough pain. We believe there is a 90% chance the company receives FDA approval on July 27. Zalviso has several advantages over intravenous delivery methods. Obamacare and favorable product pricing should benefit…
Market Commentary For Monday June 30 – New Quarter + HALO MNKD INVE
Market Commentary For Monday June 30 – New Quarter + $HALO $MNKD $INVE As predicted from last week, markets were flat down from Thursday. Tuesday should see new market money roll in, so I think names like ACRX, HALO, and…
Video For Sunday, June 29: Short Market Week + MNKD And Market Commentary
Market Commentary For Sunday June 29 – Short Market Week + MNKD And Market Commentary. In this video, I explain why Afrezza is likely never to earn the money to justify a market cap higher than $500M for $MNKD. Additionally,…